EDAP TMS S.A. First Quarter 2004 Meets Expectations

EDAP TMS S.A. First Quarter 2004 Meets Expectations
- Improved Revenues and Restructured Costs Deliver Results - 


VAULX-EN-VELIN, France, April 19  /PRNewswire-FirstCall/ -- EDAP TMS S.A. , a
global leader in the development, marketing and distribution of a portfolio of
minimally-invasive medical devices for the treatment of urological diseases,
ahead of the release of its first quarter 2004 financial results on May 12,
2004, today announced progress on its expectations.

The Company's expectations of the first quarter were based on double digit
percentage revenue growth, sustained gross margins and significant expense
reductions, versus same quarter a year ago, with the aim of operating income or
break-even in each of the two operating divisions.

Full first quarter 2004 financial results will be released, as previously
announced, on May 12, 2004, followed by a conference call on May 13, 2004.

EDAP TMS S.A. is the global leader in the development, production, marketing
and distribution of a portfolio of minimally invasive medical devices primarily
for the treatment of urological diseases. The Company currently develops and
markets devices for the minimally invasive treatment of localized prostate
cancer, using High Intensity Focused Ultrasound (HIFU), through its EDAP SA
subsidiary; it is also developing this technology for the treatment of certain
other types of tumors. EDAP TMS S.A. also produces and commercializes medical
equipment for treatment of urinary tract stones using Extra-corporeal Shockwave
Lithotripsy (ESWL), via its TMS SA subsidiary. In addition, the Company markets
in Japan and Italy devices for the non-surgical treatment of benign Prostate
Hyperplasia (BPH) using Microwave Thermotherapy (TUMT). For more information,
in the U.S., contact EDAP Technomed Inc., the Company's U.S. subsidiary located
in Atlanta, GA, by phone at [phone]. For additional information on the
Company, please see the Company's web site at: http://www.edap-tms.com/.

This press release contains, in addition to historical information,
forward-looking statements that involve risks and uncertainties. These include
statements regarding the Company's growth and expansion plans. Such statements
are based on management's current expectations and are subject to a number of
uncertainties and risks that could cause actual results to differ materially
from those described in the forward-looking statements. Factors that may cause
such a difference include, but are not limited to, those described in the
Company's filings with the Securities and Exchange Commission.

   CONTACT:  Philippe Chauveau / Blandine Confort
             33.4.72.15.31.50
             Ian Vawter - EDAP Technomed Inc.
             1.770.446.9950


DATASOURCE: EDAP TMS S.A.



CONTACT:  Philippe Chauveau or Blandine Confort, [phone], both

for EDAP TMS S.A.; or Ian Vawter - EDAP Technomed Inc., [phone]



Web site:  http://www.edap-tms.com/ 

Copyright